Consuming too much salt is a staple concern of modern nutritional science, long recognized as a primary driver of hypertension and cardiovascular disease. However, emerging research suggests the health implications of a high-salt diet (HSD) extend far beyond blood pressure. Growing evidence indicates that excessive sodium intake may also interfere with critical cognitive functions, including memory, executive thinking, and emotional well-being. As the global prevalence of high-sodium diets continues to pose a significant public health challenge, identifying novel strategies to counteract this systemic damage has become a priority for the scientific community.
A team of researchers in Japan has recently identified a promising therapeutic candidate in LPC70, a specialized compound derived from soy. Previous preliminary research had indicated that this ingredient possessed the potential to mitigate both elevated blood pressure and the associated cognitive deficits observed in mice fed a high-salt diet. A new study, published in Volume 197 of Neurochemistry International on July 1, 2026, delves deeper into the physiological mechanisms at play, revealing that LPC70 exerts its protective effects by modulating specific chemical signaling pathways in both the kidneys and the brain.
How a Soy Compound May Counter the Effects of Excess Salt
The research, led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota of the Fujita Health University Graduate School of Medical Science, centers on the role of prostaglandins (PGs). These signaling molecules, which are synthesized from a fatty acid known as arachidonic acid (AA), act as localized, hormone-like regulators throughout the human body.
In the cardiovascular system, prostaglandins are essential for maintaining vascular homeostasis, helping to control blood pressure by facilitating the rhythmic widening and narrowing of blood vessels. Their role in the central nervous system, however, is far more complex. Depending on the specific receptors they activate, prostaglandins can trigger signals that either protect delicate nerve cells from oxidative stress or, conversely, contribute to inflammatory processes that may degrade memory and emotional regulation.
LPC70 is a form of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine (LPC), which accounts for more than 70% of its phospholipid content. While earlier experiments confirmed that LPC70 could ease salt-related hypertension and cognitive difficulties, the specific pathways—particularly its influence on the intricate prostaglandin signaling network—remained largely unknown. To bridge this knowledge gap, the research team, which included Dr. Kazuhiro Kagotani of Tsuji Oil Mills Co., Ltd. and Mie University, conducted a series of controlled experiments to observe how LPC70 alters these signaling pathways in mice maintained on high-salt diets.
Dr. Kubota, who served as the study’s first author, spearheaded the experiments, assessing changes in blood pressure, monitoring behavioral shifts, and conducting molecular analyses of prostaglandin activity. By comparing these markers across different organ systems, the researchers were able to clarify how LPC70 produces distinct, organ-specific protective effects. The findings, which were released online on May 14, 2026, represent a significant step forward in understanding how dietary interventions can protect long-term health.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," noted Professor Mouri. The research was the result of a collaborative effort with Tsuji Oil Mills Co., Ltd., a company dedicated to the development of naturally derived food ingredients, underscoring the potential for translating laboratory findings into practical nutritional strategies.
Soy Compound Improves Blood Pressure and Memory in Mice
In the study, mice placed on a high-salt diet predictably developed elevated blood pressure. However, the researchers observed that the physical toll was accompanied by clear behavioral manifestations. The salt-loaded animals exhibited a marked reduction in social interaction and struggled to recognize objects they had previously encountered, which served as a reliable indicator of impaired cognitive and memory function.
Notably, the mice did not display widespread behavioral impairment; their general movement and anxiety-like behaviors remained largely unchanged. This pattern suggests that excessive salt consumption specifically targets complex social and cognitive neural circuits rather than causing indiscriminate damage to the brain’s motor or stress centers.
When the researchers introduced LPC70 into the diets of these mice, the results were striking. The supplement not only helped stabilize blood pressure but also led to measurable improvements in the animals’ performance on social interaction and object recognition memory tests. These findings prompted the team to investigate the underlying molecular changes within the kidneys and the brain to determine how the compound was "reprogramming" the animals’ response to salt.
Different Protective Effects in the Kidneys and Brain
The analysis revealed that LPC70 operates through different mechanisms depending on the tissue involved. In the kidneys, a high-salt diet was found to increase the expression of cyclooxygenase-2 (COX-2) and the PGE2 receptor EP3—two components of prostaglandin signaling strongly associated with the development of salt-induced hypertension. By supplementing with LPC70, the researchers observed a reduction in the expression of these components, effectively correcting the maladaptive signaling that drives high blood pressure.
Conversely, the team discovered a different response within the prefrontal cortex, the area of the brain responsible for high-level thinking, memory, and social behavior. Excess salt intake was found to reduce the expression of the PGD2 receptor DP1, which is critical for protective, anti-inflammatory signaling. Treatment with LPC70 successfully restored the expression of the DP1 receptor. Importantly, the compound did not alter the expression of DP2, a related receptor often linked to harmful, pro-inflammatory processes. This selectivity suggests that LPC70 does not function as a blanket suppressor of prostaglandin activity, but rather as a precise modulator that favors neuroprotective pathways.
A Surprising Change in Chemical Signaling
Perhaps the most unexpected discovery involved the body’s utilization of arachidonic acid (AA). Typically, the body requires sufficient levels of this fatty acid to produce prostaglandins. The researchers found that mice on a high-salt diet exhibited lower levels of circulating arachidonic acid. Yet, when these mice were treated with LPC70, the levels of prostaglandins derived from that fatty acid—specifically PGE2 and PGD2—actually increased.
This seemingly paradoxical finding suggests that LPC70 may enhance the metabolic efficiency of the body, allowing it to synthesize necessary prostaglandins even under the metabolic strain of a high-salt diet. By optimizing the use of available arachidonic acid, the compound helps maintain the signaling balance required for healthy organ function. The study demonstrates that the benefits of LPC70 are a result of a coordinated, selective response: suppressing hypertensive signaling in the kidneys while simultaneously restoring protective, anti-inflammatory signaling in the brain.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of these findings are substantial, suggesting that LPC70 could eventually be utilized as a functional food ingredient to mitigate the systemic health consequences of high sodium intake. Its success in improving cardiovascular and cognitive outcomes in mouse models offers a potential roadmap for addressing hypertension-related cognitive decline in humans.
However, the researchers remain cautious, noting that these findings are currently limited to animal models. Further clinical studies are required to verify whether these benefits translate to human physiology and to establish appropriate dosing and long-term safety.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," Professor Mouri concluded. As the research continues, it offers a promising glimpse into how targeted nutritional interventions might protect the brain and cardiovascular system from the pervasive, and often silent, damage caused by modern dietary habits.
The study received support through Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), with additional funding from the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe) under Japan’s Peak Research Universities (J-PEAKS) Program. Further support was provided by the Japan Science and Technology Agency FOREST Program, Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.
